Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

smart watch

- PMLiVE

FDA awards $19m in rare disease grants

US regulator supports 15 orphan drug projects

China flag thumb

Sanofi opens new Shanghai R&D headquarters

China-based hub for Asia Pacific will create 1,400 jobs

Sanofi reception

Sanofi provides bursaries to UK patient groups

Older People's Advocacy Alliance receives gold award of £25,000

- PMLiVE

Humira gets FDA nod for paediatric Crohn’s disease

Can be used as treatment for patients as young as six

- PMLiVE

Celgene’s Otezla gains new US psoriasis approval

FDA backs oral drug in moderate to severe plaque psoriasis

- PMLiVE

Apple’s HealthKit-enabled apps delayed by bug

May take two weeks to fix new software

- PMLiVE

FDA approves Lilly’s GLP-1 diabetes drug Trulicity

The once-weekly treatment is set to compete with Bydureon, Tanzeum and Victoza

Sanofi reception

Sanofi licenses cardiomyopathy programme in $200m deal

Has rights to three of MyoKardia’s programmes

- PMLiVE

Pfizer acquires option to license potential Parkinson’s treatment

Medgenesis cuts exclusive deal for its GDNF treatment

- PMLiVE

FDA approves AZ’s opioid-induced constipation drug Movantik

Trials showed positive reactions to the treatment

- PMLiVE

Vifor Pharma appoints Dario Eklund

He takes on the role of head of international business operations

- PMLiVE

FDA panel backs Novo Nordisk’s liraglutide for obesity

Committee says diabetes drug could be used to reduce weight

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links